HIV can dodge preventive antibody VRC01 after infection, trial sequencing reveals
Deep sequencing of breakthrough infections from the AMP trials shows that prophylactic VRC01 selected for low-frequency HIV escape mutations in ...
Deep sequencing of breakthrough infections from the AMP trials shows that prophylactic VRC01 selected for low-frequency HIV escape mutations in ...
A new mRNA vaccine strategy called Proactive Immune Training primes the immune system with one antigen and boosts it with ...
New research shows that introducing specific somatic hypermutations into IGHV3-53/3-66 public antibodies can dramatically expand their ability to neutralize emerging ...
More than 120,000 infants acquire HIV worldwide each year, often through transmission from an infected mother during pregnancy, birth or ...
A groundbreaking discovery in the relentless pursuit of effective HIV-1 treatments has emerged from the laboratories of the University of ...
In the relentless global quest to find a lasting solution for HIV, a groundbreaking study has illuminated new pathways toward ...
In a groundbreaking advance that promises to reshape our approach to influenza virus control, researchers have unveiled a new class ...
In a significant stride toward combating the ongoing challenges posed by the SARS-CoV-2 virus and its continually emerging variants, a ...
In a remarkable breakthrough, researchers from the University of Pittsburgh and the NIH Vaccine Research Center have revealed a cutting-edge ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine